Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFβ To Degrade APOBEC3 Restriction Factors

被引:62
|
作者
Hultquist, Judd F. [1 ,2 ]
Binka, Mawuena [3 ]
LaRue, Rebecca S. [1 ]
Simon, Viviana [3 ,4 ,5 ]
Harris, Reuben S. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Mol Cellular Dev Biol & Genet, Minneapolis, MN USA
[3] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA
[4] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA
[5] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA
关键词
HIV-1; UBIQUITINATION; COMPLEX;
D O I
10.1128/JVI.06950-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 requires the cellular transcription factor CBF beta to stabilize its accessory protein Vif and promote APOBEC3G degradation. Here, we demonstrate that both isoforms of CBF beta allow for increased steady-state levels of Vif, enhanced APOBEC3G degradation, and increased viral infectivity. This conserved functional interaction enhances the steady-state levels of Vif proteins from multiple HIV-1 subtypes and is required for the degradation of all human and rhesus Vif-sensitive APOBEC3 proteins by their respective lentiviral Vif proteins.
引用
收藏
页码:2874 / 2877
页数:4
相关论文
共 41 条
  • [21] Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins
    Zhang, Wenyan
    Chen, Gongying
    Niewiadomska, Anna Maria
    Xu, Rongzhen
    Yu, Xiao-Fang
    PLOS ONE, 2008, 3 (12):
  • [22] HIV-1 and HIV-2 Vif Interact with Human APOBEC3 Proteins Using Completely Different Determinants
    Smith, Jessica L.
    Izumi, Taisuke
    Borbet, Timothy C.
    Hagedorn, Ariel N.
    Pathak, Vinay K.
    JOURNAL OF VIROLOGY, 2014, 88 (17) : 9893 - 9908
  • [23] T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques
    Champiat, Stephane
    Garrison, Keith E.
    Raposo, Rui Andre Saraiva
    Burwitz, Benjamin J.
    Reed, Jason
    Tandon, Ravi
    York, Vanessa A.
    Newman, Laura P.
    Nimityongskul, Francesca A.
    Wilson, Nancy A.
    Almeida, Rafael R.
    Martin, Jeffrey N.
    Deeks, Steven G.
    Rosenberg, Michael G.
    Wiznia, Andrew A.
    Spotts, Gerald E.
    Pilcher, Christopher D.
    Hecht, Fredrick M.
    Ostrowski, Mario A.
    Sacha, Jonah B.
    Nixon, Douglas F.
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6073 - 6080
  • [24] Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus
    Albin, John S.
    Brown, William L.
    Harris, Reuben S.
    VIROLOGY, 2014, 450 : 49 - 54
  • [25] Comparison of the replication and persistence of simian-human immunodeficiency viruses expressing Vif proteins with mutation of the SLQYLA or HCCH domains in macaques
    Schmitt, Kimberly
    Hill, M. Sarah
    Liu, Zhenqian
    Ruiz, Autumn
    Culley, Nathan
    Pinson, David M.
    Stephens, Edward B.
    VIROLOGY, 2010, 404 (02) : 187 - 203
  • [26] Characterization of molecular attributes that influence LINE-1 restriction by all seven human APOBEC3 proteins
    Renner, Tyler Milston
    Belanger, Kasandra
    Goodwin, Laura Rose
    Campbell, Mark
    Langlois, Marc-Andre
    VIROLOGY, 2018, 520 : 127 - 136
  • [27] Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses
    Depienne, C
    Roques, P
    Créminon, C
    Fritsch, L
    Casseron, R
    Dormont, D
    Dargemont, C
    Benichou, S
    EXPERIMENTAL CELL RESEARCH, 2000, 260 (02) : 387 - 395
  • [28] Human immunodeficiency virus type 1 vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation
    DeHart, Jason L.
    Bosque, Alberto
    Harris, Reuben S.
    Planelles, Vicente
    JOURNAL OF VIROLOGY, 2008, 82 (18) : 9265 - 9272
  • [29] Functional analysis of vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G
    Ribeiro, AC
    Silva, AME
    Silva, AME
    Santa-Marta, M
    Pombo, A
    Moniz-Pereira, J
    Goncalves, J
    Barahona, I
    JOURNAL OF VIROLOGY, 2005, 79 (02) : 823 - 833
  • [30] Identification of a Cullin5-ElonginB-ElonginC E3 Complex in Degradation of Feline Immunodeficiency Virus Vif-Mediated Feline APOBEC3 Proteins
    Wang, Jiawen
    Zhang, Wenyan
    Lv, Mingyu
    Zuo, Tao
    Kong, Wei
    Yu, Xianghui
    JOURNAL OF VIROLOGY, 2011, 85 (23) : 12482 - 12491